Affiliations: [a] Department of Biology, Federal University Birnin Kebbi, Nigeria
| [b] Department of Biochemistry and Molecular Biology, Federal University Birnin Kebbi, Nigeria
Correspondence:
[*]
Address for correspondence: T.O. Yahaya, Department of Biology, Federal University Birnin Kebbi, Nigeria. Tel.: +234 8033550788; Fax: +234 8098233774; E-mails: [email protected] and [email protected].
Abstract: BACKGROUND:Precision medicine, described as a therapeutic procedure in which complex diseases are treated based on the causal gene and pathophysiology, is being considered for diabetes mellitus (DM). To this end, several monogenetic mutations in the beta cells have been linked with neonatal diabetes mellitus (NDM), however, the list of suspect genes is expansive, necessitating an update. This study, therefore, provides an update on NDM candidate genes and pathophysiology. RESULTS:Reputable online academic databases were searched for relevant information, which led to the identification of 43 genes whose mutations are linked to the condition. Of the linked genes, mutations in the KCNJ11, ABCC8, and INS genes as well as the genes on 6q24 chromosomal region are the most frequently implicated. Mutations in these genes can cause pancreatic agenesis and developmental errors, resulting in NDM in the first six to twelve months of birth. The clinical presentations of NDM include frequent urination, rapid breathing, and dehydration, among others. CONCLUSIONS:Monogenetic mutations in the beta cells may cause NDM with distinct pathophysiology from other DM. Treatment options that target NDM candidate genes and pathophysiology may lead to an improved treatment compared with the present generalized treatment for all forms of DM.
Keywords: Beta cell, KCNJ11, pancreatic agenesis, pathophysiology, precision
medicine
